TY  - GEN
AU  - Gupta,G
AU  - Stockfleth,E
AU  - Peris,K
AU  - Aractingi,S
AU  - Alomar,A
AU  - Dakovic,R
AU  - Dirschka,T
TI  - Long-term sustained lesion clearance from Lmax with imiquimod 3.75%, a new field-directed treatment for actinic keratosis
SN  - 1468-3083
PY  - 2016///0526
KW  - Adjuvants, Immunologic
KW  - administration & dosage
KW  - Administration, Topical
KW  - Aged
KW  - Aminoquinolines
KW  - Delayed-Action Preparations
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Face
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Imiquimod
KW  - Keratosis, Actinic
KW  - drug therapy
KW  - Male
KW  - Scalp
KW  - Severity of Illness Index
KW  - Skin
KW  - metabolism
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/jdv.12697
ER  -